Solving the Medicare Co-Pay Dilemma

Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases

What Your Board Needs to Know About Market Access and Oncology: A Webinar for Top Management

Gene therapy virtual event with HBO’s Axios this Monday, May 4, 2020

Real-World Noise, Trends, Realities, and Implications on the Road to Value-Based Contracting in Cancer Care

Panel: Drug Pricing and Value Based Reimbursement

Panel: Myth vs. Reality – Implementing payment arrangments for cell and gene therapies

Congratulations Susan!

NewYorkBio 2019 Annual Meeting

Bio CEO and Investor Conference: Navigating Payers’ Expectations for Value-Based Agreements